SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-12-196740
Filing Date
2012-04-30
Accepted
2012-04-30 17:27:03
Documents
10

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT NO. 2 d344004d424b3.htm 424B3 311093
2 GRAPHIC g341972g18r68.jpg GRAPHIC 7111
3 GRAPHIC g341972g19w92.jpg GRAPHIC 14788
4 GRAPHIC g341972img001.jpg GRAPHIC 4594
5 GRAPHIC g341972img002.jpg GRAPHIC 848
6 GRAPHIC g341972img003.jpg GRAPHIC 870
7 GRAPHIC g341972img004.jpg GRAPHIC 674
8 GRAPHIC g341972img005.jpg GRAPHIC 817
9 GRAPHIC g341972img006.jpg GRAPHIC 5985
10 GRAPHIC g344004g26q30.jpg GRAPHIC 30156
  Complete submission text file 0001193125-12-196740.txt   404260
Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Filer) CIK: 0001401667 (see all company filings)

IRS No.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-178308 | Film No.: 12796685
SIC: 2834 Pharmaceutical Preparations